The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease.
about
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.Pharmacotherapy in sickle cell disease--state of the art and future prospectsMassive accidental overdose of hydroxyurea in a young child with sickle cell anemiaPharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.Hydroxyurea for children with sickle cell diseaseDevelopment of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaRole of hydroxycarbamide in prevention of complications in patients with sickle cell disease.Management of the Dialysis Patient with Sickle Cell Disease.Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease.Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters.Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models.
P2860
Q33297034-D294E5DB-840C-4677-BC5A-D0A4F1480E7CQ34047294-5F575BE1-779B-47FD-9C60-C0B5BE1846DBQ34171747-0B0DB6EF-ACA0-4E3B-9EA8-4F8388825D0FQ35220342-EE90C83D-24C8-4D4C-AB57-18CC7FEBE4BCQ35353627-A223F06F-47C7-4645-9360-06B72D152A50Q35525659-4EDB1868-44BA-4B66-BB20-F5A1A8471583Q36612962-9D55C492-087C-49CA-853E-91BB43ABFAC2Q36706798-04ECC626-DD07-4FE9-ABBE-6AE4E7AAF8F5Q36966277-4C5C760B-2620-48FA-9543-E452C818BFB8Q37367662-DCC3F81C-13BB-470D-A762-AC8070F6F780Q38547177-B6EC7439-0E78-4829-8777-1FD8068D22AEQ46906655-5040F1C5-F643-46B1-B50D-ED94976FC89BQ46922191-48917400-739F-41C7-B893-0D0F4CD33C29Q47145599-2DA42F2D-F25B-4F21-A2A8-5F20BE426BBDQ48036749-32E0081B-6207-4838-AE18-E4A3130AA745
P2860
The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The influence of renal functio ...... ults with sickle cell disease.
@en
The influence of renal functio ...... ults with sickle cell disease.
@nl
type
label
The influence of renal functio ...... ults with sickle cell disease.
@en
The influence of renal functio ...... ults with sickle cell disease.
@nl
prefLabel
The influence of renal functio ...... ults with sickle cell disease.
@en
The influence of renal functio ...... ults with sickle cell disease.
@nl
P2093
P2860
P356
P1476
The influence of renal functio ...... ults with sickle cell disease.
@en
P2093
Abdulah Kutlar
Dennis M Grasela
Eugene Orringer
Jeffery S Olson
Jing-He Yan
Kenneth Ataga
Samantha Gothelf
Sanjeev Kaul
P2860
P304
P356
10.1177/0091270004273526
P577
2005-04-01T00:00:00Z